HMG-CoA reductase inhibitor
HMG-CoA reductase inhibitor. Synthetic analog of Lovastatin (Prod. No. BML-G226). Inhibits the biosynthesis of isoprenoids and prevents small G protein activation. Displays lipid lowering and antihypertensive effects. Displays antiinflammatory, immunomodulatory effects as well as protective effects in experimental traumatic brain injury. Activates Rac1-dependent signalling pathway.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
| Appearance |
White solid. |
|---|---|
| CAS |
79902-63-9 |
| Couple Target |
HMG-CoA reductase |
| Couple Type |
Inhibitor |
| Formula |
C25H38O5 |
| MI |
14: 8539 |
| MW |
418.6 |
| Purity |
≥95% |
| RTECS |
EK7798000 |
| Solubility |
Chloroform (slightly), Methanol (slightly). |
Handling & Storage
| Use/Stability |
As indicated on product label or CoA when stored as recommended. Stable for at least 1 year after receipt when stored, as supplied, at -20°C. Stock solutions are stable for up to 3 months at -20°C. |
|---|---|
| Long Term Storage |
-20°C |
| Shipping |
Blue Ice |
| Regulatory Status |
RUO – Research Use Only |
|---|
- EmbryoNet: using deep learning to link embryonic phenotypes to signaling pathways: Čapek, D., Safroshkin, M., et al.; Nat. Methods 20, 815 (2023), Abstract
- Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer’s disease: X.K. Tong, et al.; Cell Death Dis. 13, 325 (2022), Abstract
- Polycaprolactone-collagen nanofibers loaded with dexamethasone and simvastatin as an osteoinductive and immunocompatible scaffold for bone regeneration applications: H.A. Rather, et al.; Biomater. Biosyst. 8, 100064 (2022), Abstract
- Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation: L. Voss, et al.; Pharmaceuticals (Basel) 14, 727 (2021), Abstract
- Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters: M. Mehibel, et al.; Sci. Rep. 8, 16804 (2018), Abstract — Full Text
- MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery: Young, J., Margaron, Y., et al.; SLAS Discov. 23, 790 (2018), Abstract
- Simvastatin Enhances Activity and Trafficking of α7 Nicotinic Acetylcholine Receptor in Hippocampal Neurons Through PKC and CaMKII Signaling Pathways: Chen, T., Wang, Y., et al.; Front. Pharmacol. 9, 362 (2018), Abstract
- Simvastatin prevents β-amyloid 25-35-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate: C. Wang, et al.; Neuropharmacology 97, 122 (2015), Application(s): Oral administration to male mice, Abstract
- Beyond lipid lowering: the anti-hypertensive role of statins: V. Chopra, et al.; Cardiovasc. Drugs Ther. 21, 161 (2007), Abstract
- Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury: H. Wang, et al.; Exp. Neurol. 206, 59 (2007), Abstract
- HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced inside-out” signaling to extracellular matrix by preventing RhoA activation”””: H. Xu, et al.; Am. J. Physiol. Renal Physiol. 291, F995 (2006), Abstract
- Breast cancer growth prevention by statins: Campbell, M. J., Esserman, L. J., et al.; Cancer Res. 66, 8707 (2006), Abstract
- Anti-inflammatory and immunomodulatory effects of statins: L.M. Blanco-Colio, et al.; Kidney Int. 63, 12 (2003), Abstract
- 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy: F.R. Danesh, et al.; Proc Natl Acad Sci USA 99, 8301 (2002), Abstract
- Lovastatin and simvastatin are modulators of the proteasome: C. Wojcik, et al.; Int. J. Biochem. Cell Biol. 32, 957 (2000), Abstract
Related Products
| CAS | 38966-21-1 |
|---|---|
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | (+)-3,3’,4’,5,7-Flavanpentol . H2O |
|---|---|
| CAS | 225937-10-0 |
| Purity | ≥98% (HPLC) |
| Alternative Name | (3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-(3H)-furanone |
|---|---|
| CAS | 7770-78-7 |
| Couple Type | Inhibitor |
| Purity | ≥97% (HPLC) |
| Alternative Name | (3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]-3-[[4-(β-D-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-2(3H)-furanone |
|---|---|
| CAS | 20362-31-6 |
| Couple Type | Inhibitor |
| Purity | ≥95% (HPLC) |
Last modified: May 29, 2024
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form
Lab Essentials
AMPIVIEW® RNA probes
Enabling Your Projects
GMP Services
Bulk Solutions
Research Travel Grant
Have You Published Using an Enzo Product?